You can help expand this article with text translated from the corresponding article in French. (November 2024) Click [show] for important translation instructions.
|
Company type | Public |
---|---|
Euronext: BOI | |
Industry | Alternative medicine |
Founded | 7 June 1932 |
Founders | Jean Boiron Henri Boiron |
Headquarters | Messimy, France |
Area served | worldwide |
Key people | Valérie Poinsot (CEO) |
Revenue | 604 million € (2018) |
57.4 million € (2018) | |
Number of employees | 3,723 |
Website | www |
Boiron (French pronunciation: [bwaʁɔ̃]) is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.[1]
Products of Boiron include mono- (Hahnemanian) and poly-preparations, which Boiron refer to as "proprietary drugs".[citation needed]
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect,[2][3][4] and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive.[5][6][7][8]